Nai-Kui Liu Selected Research

bisperoxovanadium

1/2019	Bisperoxovanadium Mediates Neuronal Protection through Inhibition of PTEN and Activation of PI3K/AKT-mTOR Signaling after Traumatic Spinal Injuries.
2/2015	Biphasic bisperoxovanadium administration and Schwann cell transplantation for repair after cervical contusive spinal cord injury.
1/2012	Systemic bisperoxovanadium activates Akt/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nai-Kui Liu Research Topics

Disease

19	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 04/2006
6	Wounds and Injuries (Trauma) 01/2018 - 06/2008
5	Inflammation (Inflammations) 09/2012 - 04/2006
3	Demyelinating Diseases (Demyelinating Disease) 01/2016 - 04/2006
2	Atrophy 01/2021 - 01/2018
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 05/2011 - 06/2010
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Spinal Injuries (Spinal Injury) 01/2019
1	Stroke (Strokes) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2011
1	Multiple Trauma (Multiple Injuries) 06/2008
1	Necrosis 04/2006

Drug/Important Bio-Agent (IBA)

7	Phospholipases A2 (Phospholipase A2)IBA 01/2021 - 04/2006
4	Neuroprotective AgentsIBA 01/2021 - 10/2007
3	salicylhydroxamic acid (SHAM)IBA 01/2021 - 08/2012
3	bisperoxovanadiumIBA 01/2019 - 01/2012
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021 - 03/2013
2	TensinsIBA 01/2019 - 01/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 01/2012
2	Testosterone (Sustanon)FDA Link 01/2018 - 08/2012
2	baysilon (polydimethylsiloxane)IBA 01/2018 - 08/2012
2	Phospholipases (Phospholipase)IBA 12/2011 - 06/2008
2	MicroRNAs (MicroRNA)IBA 05/2011 - 10/2009
2	Nonesterified Fatty Acids (NEFA)IBA 06/2010 - 06/2008
2	Secretory Phospholipases A2IBA 11/2009 - 06/2008
1	arachidonyltrifluoromethaneIBA 01/2021
1	Laminin (Merosin)IBA 01/2021
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020
1	Dihydrotestosterone (Androstanolone)IBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 01/2016
1	Acrolein (Aqualin)IBA 01/2016
1	Arachidonic Acid (Vitamin F)IBA 05/2014
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	Protein Isoforms (Isoforms)IBA 05/2014
1	Free RadicalsIBA 09/2012
1	Glutamic Acid (Glutamate)FDA Link 09/2012
1	TOR Serine-Threonine KinasesIBA 01/2012
1	Platelet Activating FactorIBA 06/2010
1	EicosanoidsIBA 06/2010
1	Annexin A1IBA 10/2007
1	Actins (F Actin)IBA 12/2006
1	Melitten (Melittin)IBA 04/2006
1	Quinacrine (Mepacrine)IBA 04/2006

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2012
2	Transplantation 02/2015 - 01/2013
2	Injections 09/2007 - 04/2006